EP 3746081 A1 20201209 - NOVEL USES
Title (en)
NOVEL USES
Title (de)
NEUARTIGE VERWENDUNGEN
Title (fr)
NOUVELLES UTILISATIONS
Publication
Application
Priority
- US 201862624705 P 20180131
- US 201862683431 P 20180611
- US 201862700126 P 20180718
- US 2019016128 W 20190131
Abstract (en)
[origin: WO2019152697A1] The disclosure provides methods, treatments and materials for enhancing the effect of an adenosine A2 receptor agonist in the treatment, mitigation or prophylaxis of a disease or condition characterized by inotropic and/or lusitropic dysfunction, and/or enhancing adenosine A2 receptor function in the treatment, mitigation or prophylaxis of a disease or condition characterized by impaired adenosine A2 receptor function, comprising administration of an effective amount of a PDE1 inhibitor to a patient in need thereof, for example a patient suffering from heart failure.
IPC 8 full level
A61K 31/519 (2006.01); A61P 9/00 (2006.01); C07D 487/14 (2006.01)
CPC (source: EP US)
A61K 9/0053 (2013.01 - US); A61K 31/04 (2013.01 - US); A61K 31/137 (2013.01 - EP); A61K 31/197 (2013.01 - US); A61K 31/216 (2013.01 - US); A61K 31/41 (2013.01 - US); A61K 31/4178 (2013.01 - US); A61K 31/519 (2013.01 - EP US); A61K 31/7056 (2013.01 - US); A61K 45/06 (2013.01 - EP US); A61P 9/00 (2018.01 - EP); A61P 9/04 (2018.01 - US); C07D 487/14 (2013.01 - EP)
C-Set (source: EP)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2019152697 A1 20190808; EP 3746081 A1 20201209; EP 3746081 A4 20211027; JP 2021513518 A 20210527; JP 7401442 B2 20231219; US 11759465 B2 20230919; US 11839614 B2 20231212; US 2020289519 A1 20200917; US 2021205307 A1 20210708; US 2023338385 A1 20231026; US 2024091232 A1 20240321
DOCDB simple family (application)
US 2019016128 W 20190131; EP 19747990 A 20190131; JP 2020541880 A 20190131; US 201916966818 A 20190131; US 202016892206 A 20200603; US 202318344406 A 20230629; US 202318501330 A 20231103